Report reveals need for African-based producers of MH supplies

In our latest report, co-authored by the Reproductive Health Supplies Coalition (RHSC), we analyzed the demand for and manufacturing capacity of five essential maternal health commodities across eight countries in sub-Saharan Africa. The report found a lack of diversified regional suppliers, an over-reliance on foreign imports, and varying capacity and distribution of regional manufacturers. These factors negatively impact availability, access, and affordability of essential maternal health medicines.

Read the report

Read the blog

Renovated labs in the Democratic Republic of Congo to improve quality testing

Black female lab worker with safety glasses analyzing test tubes

In the Democratic Republic of Congo, we’re working with national authorities to redesign and rehabilitate the national physio-chemical, microbiology, and medical device laboratories. This project will improve quality testing of medicines and medical devices nationwide to protect patients from poor-quality medical products and strengthen laboratory capacity and sustainability.

Learn more

Mark your calendars

Spotlight on World Vaccine Congress

Join us from April 1-4, 2024 in Washington, DC for the World Vaccine Congress, where we’re participating in three sessions that highlight innovation in vaccine manufacturing, strengthening pharmacovigilance programs in Africa, and developing vaccine standards to ensure quality raw materials and finished products.

In case you missed it

New course: Impurities

Don’t miss our new on-demand course, Impurities in Drug Products and Drug Substances - A USP Approach, which covers guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and U.S. Food and Drug Administration (FDA) policy on impurities, relevant USP General Chapters, and our approach to impurities in monographs.

Received this message from a friend? Click here to subscribe.